Mizuho Reiterates Buy on Inspire Medical Systems, Maintains $300 Price Target
Portfolio Pulse from richadhand@benzinga.com
Mizuho analyst Anthony Petrone reiterated a Buy rating on Inspire Medical Systems (NYSE:INSP) and maintained a $300 price target.
June 12, 2023 | 1:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mizuho analyst Anthony Petrone reiterated a Buy rating on Inspire Medical Systems (INSP) and maintained a $300 price target.
The news of Mizuho analyst reiterating a Buy rating and maintaining a $300 price target on Inspire Medical Systems (INSP) is positive for the stock. This reaffirms the analyst's confidence in the company's growth potential and could lead to increased investor interest, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100